INNOSPEC INC.

For the period ended Mar 31, 2026. Filed May 8, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 8, 2026

IOSP$80.21+2.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(in millions, except share and per share data)	March 31,2026	December 31,2025
Assets
Current assets:
Cash and cash equivalents	$289.1	$292.5
Trade and other accounts receivable (less allowances of $14.2 million and $11.8 million respectively)	354.2	342.3
Inventories (less allowances of $39.4 million and $40.4 million respectively):
Finished goods	225.6	226.3
Raw materials	95.9	103.0
Total inventories	321.5	329.3
Prepaid expenses	16.9	20.1
Prepaid income taxes	10.6	13.1
Other current assets	6.8	7.3
Total current assets	999.1	1,004.6
Net property, plant and equipment	285.7	286.1
Operating lease right-of-use assets	50.6	52.7
Goodwill	399.1	399.0
Other intangible assets	68.9	67.7
Deferred tax assets	13.0	13.6
Other non-current assets	3.4	8.7
Total assets	$1,819.8	$1,832.4

Liabilities and Equity
Current liabilities:
Accounts payable	$138.5	$174.7
Accrued liabilities	169.3	152.3
Current portion of operating lease liabilities	15.1	15.9
Current portion of plant closure provisions	4.9	4.9
Current portion of acquisition-related contingent consideration	2.7	7.0
Accrued income taxes	4.3	5.3
Total current liabilities	334.8	360.1
Operating lease liabilities, net of current portion	35.5	36.8
Plant closure provisions, net of current portion	60.8	60.2
Deferred tax liabilities	17.9	19.1
Pension liabilities and post-employment benefits	12.8	13.2
Acquisition-related contingent consideration	1.3	1.3
Other non-current liabilities	4.5	8.8
Total liabilities	467.6	499.5
Equity:
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares	0.3	0.3
Additional paid-in capital	377.3	376.5
Treasury stock (4,836,364 and 4,776,918 shares at cost, respectively)	(121.4)	(115.2)
Retained earnings	1,129.6	1,099.2
Accumulated other comprehensive loss	(40.8)	(34.7)
Total Innospec stockholders’ equity	1,345.0	1,326.1
Non-controlling interest	7.2	6.8
Total equity	1,352.2	1,332.9
Total liabilities and equity	$1,819.8	$1,832.4

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.